Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report
Abstract Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-09-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.4545 |
| _version_ | 1818720328988229632 |
|---|---|
| author | Katsuhisa Sekido Shuichi Imaue Kei Tomihara Hidetake Tachinami Kentaro Yamagishi Seisuke Okazawa Atsushi Ikeda Kumiko Fujiwara Makoto Noguchi |
| author_facet | Katsuhisa Sekido Shuichi Imaue Kei Tomihara Hidetake Tachinami Kentaro Yamagishi Seisuke Okazawa Atsushi Ikeda Kumiko Fujiwara Makoto Noguchi |
| author_sort | Katsuhisa Sekido |
| collection | DOAJ |
| description | Abstract Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective. |
| first_indexed | 2024-12-17T20:21:06Z |
| format | Article |
| id | doaj.art-dcac5a75008c4ce2b5893600238b0f19 |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-12-17T20:21:06Z |
| publishDate | 2021-09-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-dcac5a75008c4ce2b5893600238b0f192022-12-21T21:33:56ZengWileyClinical Case Reports2050-09042021-09-0199n/an/a10.1002/ccr3.4545Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case reportKatsuhisa Sekido0Shuichi Imaue1Kei Tomihara2Hidetake Tachinami3Kentaro Yamagishi4Seisuke Okazawa5Atsushi Ikeda6Kumiko Fujiwara7Makoto Noguchi8Department of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City JapanDepartment of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City JapanDepartment of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City JapanDepartment of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City JapanDepartment of Radiology Faculty of Medicine University of Toyama Toyama City JapanFirst Department of Internal Medicine Faculty of Medicine University of Toyama Toyama City JapanDepartment of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City JapanDepartment of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City JapanDepartment of Oral and Maxillofacial Surgery Faculty of Medicine University of Toyama Toyama City JapanAbstract Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.https://doi.org/10.1002/ccr3.4545anti‐PD‐1complete remissionimmune checkpoint inhibitorlung metastasisnivolumaboral squamous cell carcinoma |
| spellingShingle | Katsuhisa Sekido Shuichi Imaue Kei Tomihara Hidetake Tachinami Kentaro Yamagishi Seisuke Okazawa Atsushi Ikeda Kumiko Fujiwara Makoto Noguchi Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report Clinical Case Reports anti‐PD‐1 complete remission immune checkpoint inhibitor lung metastasis nivolumab oral squamous cell carcinoma |
| title | Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report |
| title_full | Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report |
| title_fullStr | Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report |
| title_full_unstemmed | Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report |
| title_short | Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report |
| title_sort | durable complete response to immunotherapy with anti pd 1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis a case report |
| topic | anti‐PD‐1 complete remission immune checkpoint inhibitor lung metastasis nivolumab oral squamous cell carcinoma |
| url | https://doi.org/10.1002/ccr3.4545 |
| work_keys_str_mv | AT katsuhisasekido durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport AT shuichiimaue durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport AT keitomihara durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport AT hidetaketachinami durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport AT kentaroyamagishi durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport AT seisukeokazawa durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport AT atsushiikeda durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport AT kumikofujiwara durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport AT makotonoguchi durablecompleteresponsetoimmunotherapywithantipd1antibodynivolumabinapatientwithoralsquamouscellcarcinomapresentingwithlungmetastasisacasereport |